Guggenheim Capital LLC Enzo Biochem Inc Transaction History

Guggenheim Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$5.06 - $6.78 $59,657 - $79,936	-11,790 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$5.43 - $8.36 $1,460 - $2,248	269 Added 2.33%	11,790 $65,000
Q4 2017 Feb 14, 2018	SELL	$8.15 - $10.55 $14,751 - $19,095	-1,810 Reduced 13.58%	11,521 $93,000
Q3 2017 Nov 14, 2017	BUY	$10.45 - $11.44 $139,308 - $152,506	13,331	13,331 $139,000

15.5M

2.3K

Ticker ENZ
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 48,720,500
Market Cap $37M
Description
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Guggenheim Capital LLC with notifications on news.